Vaccines for Kids, a Global Surge in Cases, and More Coronavirus News

Vaccinating children spurs controversy, the Delta variant fuels a global surge, and drugmakers and countries consider boosters. Here’s what you should know:

Want to receive this weekly roundup and other coronavirus news? Sign up here!

Headlines

Vaccinating kids is poised to be the next politicized pandemic issue in the US

you can check here
this link
see post
next
click reference
visit site
look here
try this web-site
Going Here
click to read
check this site out
go to website
you can look here
read more
more
explanation
use this link
a knockout post
best site
blog here
her explanation
discover this info here
he has a good point
check my source
straight from the source
anonymous
go to my blog
hop over to these guys
find here
article
click to investigate
look at here now
here are the findings
view
click to find out more
important site
click here to investigate
browse around this site
click for more
why not try here
important link
address
hop over to this web-site
my website
browse around here
Recommended Site
Your Domain Name
Web Site
click this site
hop over to this site
i was reading this
click here to read
read here
i loved this
my blog
click now
you can try these out
informative post
top article
useful site
click this over here now
moved here
resource
about his
navigate to this site
click this
click here for more info
investigate this site
more helpful hints
read
over at this website
find
go to the website
try this site
look at more info
look what i found
Full Report
websites
Extra resources
get more

This week, Tennessee fired its top vaccine official for notifying health care providers of a long-standing legal mechanism that allows minors over 14 to be vaccinated without parental consent. The state has also stopped all online vaccination outreach to teens. This news, coupled with the CDC’s recent relaxation of guidelines for wearing masks inside school buildings, could well be an omen of the next big Covid controversy: vaccinating children. Clinical trials testing mRNA vaccines for kids are well underway, and first requests for emergency authorization are expected in September or October. But if they’re approved, shots for kids seem likely to become a political battleground rife with misinformation.

On Thursday, US surgeon general Vivek Murthy called misinformation about Covid-19 and vaccines more generally a pressing national concern, especially as vaccination rates have slowed and cases are once again on the rise. He called on tech companies in particular to make changes to their platforms to stop the spread of unfounded or inaccurate claims about the pandemic.

The Delta variant continues to spur a surge in cases around the world and in the US

Global outbreaks are worsening as the Delta variant continues to spread rapidly. The WHO reported that deaths in Africa rose by 43 percent in the last week, South Korea has tightened restrictions as it battles its worst outbreak yet, and Covid wards are overflowing in Indonesia, the world’s fourth-most-populous country. The surge is particularly bad in countries with lower vaccination rates, but fortunately some vaccine sharing efforts seem to be picking up speed. Late this week, for instance, Indonesia received 1.5 million doses of the Moderna vaccine following 3 million other American doses that arrived last weekend.

Delta is now also the dominant strain in the US, and case counts are going up in every state. In response to this surge, Los Angeles reinstated its indoor mask mandate for everyone—vaccinated or not.

Some countries weigh offering booster shots despite calls to prioritize first doses

Israel has started offering a third booster dose of the Pfizer-BioNTech vaccine to immunocompromised adults after the Delta variant sent case rates up again, even among people who have already been vaccinated. The country’s health minister said the decision on whether to make boosters more widely available is pending. Pfizer has been pitching boosters in the US as well, but senior US officials told the drugmaker that they would need more data on the efficacy of a third dose before approving it for use. Even so, a federal advisory panel is expected to meet next week to weigh the possibility of giving additional doses to patients with suppressed immunity.

Leave a Reply

Your email address will not be published. Required fields are marked *